Insmed Inc $13.65

down -0.08


20/8/2014 10:35 AM  |  NASDAQ : INSM  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get INSM Trend Analysis - it has underperformed the S&P 500 by 1%

Partner Headlines

  1. Markets Rise; Macy's Lowers Comparable Sales Outlook

    Benzinga
  2. Benzinga's Volume Movers

    Benzinga
  3. Dow Breaks Four Day Losing Streak As Calm Restores Last Week's Jittery ...

    Benzinga
  4. Indexes Reverse Losses; Michael Kors Beats Expectations Again

    Benzinga
  5. Alere Drops On Downbeat Results; Trex Shares Surge

    Benzinga
  6. Markets Open Higher; Michael Kors Results Beat Street View

    Benzinga
  7. Morning Market Losers

    Benzinga
  8. Benzinga's Top #PreMarket Losers

    Benzinga
  9. Events Scheduled for Week of Jun 23rd to Jun 27th, 2014

    Benzinga
  10. Mid-Afternoon Market Update: Fed Tapers Another $10B; Will Purchase $15B/Month ...

    Benzinga
  11. Mid-Day Market Update: US Stocks Slide Ahead Of Fed Decision; Adobe Shares ...

    Benzinga
  12. Mid-Morning Market Update: Markets Mostly Flat; FedEx Results Top Street ...

    Benzinga
  13. Benzinga's Volume Movers

    Benzinga
  14. Morning Market Movers

    Benzinga
  15. Insmed Up Over 30% Following FDA Decision

    Benzinga
  16. Benzinga's Top #PreMarket Gainers

    Benzinga
  17. Insmed Shares Rally Over $14 As Piper Jaffray Boosts Price Target To $51

    Benzinga
  18. Mid-Afternoon Market Update: American Capital Rises as MannKind Shares ...

    Benzinga
  19. Mid-Day Market Update: Nordion Surges On Acquisition News; BlackBerry Shares ...

    Benzinga
  20. Insmed falls on mixed results

    IBD
  21. Market Wrap For March 26: Markets Close Near Session Lows In Yet Another ...

    Benzinga
  22. Insmed Falls On Mixed Results For Lung Drug

    IBD
  23. Morning Market Losers

    Benzinga
  24. Benzinga's Top #PreMarket Losers

    Benzinga
  25. UPDATE: Insmed Says Arikayce Did Not Meet Pre-Specified Level for Statistical ...

    Benzinga
  26. Benzinga's Top #PreMarket Gainers

    Benzinga
  27. Benzinga's Top #PreMarket Losers

    Benzinga
  28. UPDATE: Piper Jaffray Initiates Coverage on Insmed as 2014 Biotech Sector ...

    Benzinga
  29. Market Wrap For Tuesday, October 15: Earnings Reports And White House Progress ...

    Benzinga
  30. Mid-Afternoon Market Update: Tumi Holdings Rises Amid Market Decline

    Benzinga
  31. Insmed Reports Issuance of Two Patents

    Benzinga
  32. Leerink Swann Reiterates Outperform on Insmed Following MEDACorp KOL Checks

    Benzinga
  33. Weekly CEO Buys Highlight: TPGI, INSM, EQU, FCEL

    GuruFocus
  34. Insmed Names Lewis CEO

    Benzinga
  35. Insmed Inc. Reports Operating Results (10-Q)

    GuruFocus
  36. Insmed up 12% After Insider Share Purchase

    Benzinga
  37. Insmed Provides Corporate Update; Projects Cash Sufficient to Generate ...

    Benzinga
  38. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical ...

    Benzinga
  39. Insmed Skyrockets 70% after FDA Lifts Clinical Hold

    Benzinga
  40. Benzinga's Microcap Movers for Friday January 20, 2012

    Benzinga
  41. Insmed Surges after Clinical Hold Lifted by FDA

    Benzinga
Trading Center